ACM Biolabs Additional Strengthens Management, Appoints David Lawrence to Board of Administrators
SINGAPORE, April 11, 2023 /PRNewswire/ — ACM Biolabs (FR0012596468 – ALSEN) a pioneering Singaporean-Swiss biotechnology firm, which specializes within the growth of focused therapeutics for the prevention of a number…